Fluctuations in response to treatment for Parkinson's disease
Identifieur interne :
000232 ( PascalFrancis/Curation );
précédent :
000231;
suivant :
000233
Fluctuations in response to treatment for Parkinson's disease
Auteurs : John G. Nutt [
États-Unis]
Source :
-
Advances in neurology [ 0091-3952 ] ; 2001.
RBID : Pascal:03-0237963
Descripteurs français
English descriptors
pA |
A01 | 01 | 1 | | @0 0091-3952 |
---|
A02 | 01 | | | @0 ADNRA3 |
---|
A03 | | 1 | | @0 Adv. neurol. |
---|
A05 | | | | @2 86 |
---|
A08 | 01 | 1 | ENG | @1 Fluctuations in response to treatment for Parkinson's disease |
---|
A09 | 01 | 1 | ENG | @1 Parkinson's disease |
---|
A11 | 01 | 1 | | @1 NUTT (John G.) |
---|
A12 | 01 | 1 | | @1 CALNE (Donald) @9 ed. |
---|
A12 | 02 | 1 | | @1 CALNE (Susan M.) @9 ed. |
---|
A14 | 01 | | | @1 Departments of Neurology, Oregon Health Sciences University @2 Portland, Oregon 97201 @3 USA @Z 1 aut. |
---|
A15 | 01 | | | @1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut. |
---|
A18 | 01 | 1 | | @1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr. |
---|
A18 | 02 | 1 | | @1 Pacific Parkinsons Research Institute @3 CAN @9 patr. |
---|
A20 | | | | @1 361-366 |
---|
A21 | | | | @1 2001 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 15741 @5 354000109446770370 |
---|
A44 | | | | @0 0000 @1 © 2003 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 51 ref. |
---|
A47 | 01 | 1 | | @0 03-0237963 |
---|
A60 | | | | @1 P @2 C |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Advances in neurology |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B17G |
---|
C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
---|
C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
---|
C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
---|
C03 | 02 | X | FRE | @0 Antiparkinsonien @5 16 |
---|
C03 | 02 | X | ENG | @0 Antiparkinson agent @5 16 |
---|
C03 | 02 | X | SPA | @0 Antiparkinsoniano @5 16 |
---|
C03 | 03 | X | FRE | @0 Fluctuation @5 17 |
---|
C03 | 03 | X | ENG | @0 Fluctuations @5 17 |
---|
C03 | 03 | X | SPA | @0 Fluctuación @5 17 |
---|
C03 | 04 | X | FRE | @0 Traitement @5 18 |
---|
C03 | 04 | X | ENG | @0 Treatment @5 18 |
---|
C03 | 04 | X | SPA | @0 Tratamiento @5 18 |
---|
C03 | 05 | X | FRE | @0 Chimiothérapie @5 19 |
---|
C03 | 05 | X | ENG | @0 Chemotherapy @5 19 |
---|
C03 | 05 | X | SPA | @0 Quimioterapia @5 19 |
---|
C03 | 06 | X | FRE | @0 Homme @5 20 |
---|
C03 | 06 | X | ENG | @0 Human @5 20 |
---|
C03 | 06 | X | SPA | @0 Hombre @5 20 |
---|
C07 | 01 | X | FRE | @0 Encéphale pathologie @5 37 |
---|
C07 | 01 | X | ENG | @0 Cerebral disorder @5 37 |
---|
C07 | 01 | X | SPA | @0 Encéfalo patología @5 37 |
---|
C07 | 02 | X | FRE | @0 Extrapyramidal syndrome @5 38 |
---|
C07 | 02 | X | ENG | @0 Extrapyramidal syndrome @5 38 |
---|
C07 | 02 | X | SPA | @0 Extrapiramidal síndrome @5 38 |
---|
C07 | 03 | X | FRE | @0 Maladie dégénérative @5 39 |
---|
C07 | 03 | X | ENG | @0 Degenerative disease @5 39 |
---|
C07 | 03 | X | SPA | @0 Enfermedad degenerativa @5 39 |
---|
C07 | 04 | X | FRE | @0 Système nerveux central pathologie @5 40 |
---|
C07 | 04 | X | ENG | @0 Central nervous system disease @5 40 |
---|
C07 | 04 | X | SPA | @0 Sistema nervosio central patología @5 40 |
---|
C07 | 05 | X | FRE | @0 Système nerveux pathologie @5 41 |
---|
C07 | 05 | X | ENG | @0 Nervous system diseases @5 41 |
---|
C07 | 05 | X | SPA | @0 Sistema nervioso patología @5 41 |
---|
N21 | | | | @1 146 |
---|
N82 | | | | @1 PSI |
---|
|
pR |
A30 | 01 | 1 | ENG | @1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25 |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A91
Links to Exploration step
Pascal:03-0237963
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Fluctuations in response to treatment for Parkinson's disease</title>
<author><name sortKey="Nutt, John G" sort="Nutt, John G" uniqKey="Nutt J" first="John G." last="Nutt">John G. Nutt</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology, Oregon Health Sciences University</s1>
<s2>Portland, Oregon 97201</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237963</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237963 INIST</idno>
<idno type="RBID">Pascal:03-0237963</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A91</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000232</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Fluctuations in response to treatment for Parkinson's disease</title>
<author><name sortKey="Nutt, John G" sort="Nutt, John G" uniqKey="Nutt J" first="John G." last="Nutt">John G. Nutt</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology, Oregon Health Sciences University</s1>
<s2>Portland, Oregon 97201</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Fluctuations</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Antiparkinsonien</term>
<term>Fluctuation</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Fluctuations in response to treatment for Parkinson's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>NUTT (John G.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Departments of Neurology, Oregon Health Sciences University</s1>
<s2>Portland, Oregon 97201</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>361-366</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770370</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>51 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237963</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>16</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>16</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>16</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Fluctuation</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Fluctuations</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Fluctuación</s0>
<s5>17</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000232 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000232 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:03-0237963
|texte= Fluctuations in response to treatment for Parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |